Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

Clinical trial NCT02470468 · COMPLETED

Trial details

NCT number: NCT02470468
Sponsor: SOTIO a.s.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Non-small Cell Lung Cancer

Start date: 2014-12-01
Primary completion: 2018-01-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.